Rb plays important roles in regulating hematopoiesis, particularly erythropoiesis. In an effort to understand whether Rb function can be mediated by E2F transcription factors in a bone marrow-derived hematopoietic system in mice, we uncovered a functional synergy between Rb and E2F8 to promote erythropoiesis and to prevent anemia. Specifically, while Mx1-Cremediated inactivation of Rb or E2f8 in hematopoietic stem cells only led to mild erythropoietic defects, concomitant inactivation of both genes resulted in marked ineffective erythropoiesis and mild hemolysis, leading to severe anemia despite the presence of enhanced extramedullary erythropoiesis. Interestingly, although ineffective erythropoiesis is already present in the Rb Δ /Δ mice and exacerbated in the Rb Δ /Δ ;E2f8 Δ /Δ mice, hemolysis is exclusively manifested in the double knockout mice. Using an adoptive transfer system and an erythroid-specific knockout system, we showed that the synergy of Rb-and E2f8-deficiency in triggering severe anemia is intrinsic to the erythroid lineage. Surprisingly, concomitant inactivation of Rb and E2f7, a close family member of E2f8, did not substantially worsen the erythropoietic defect resulted from Rbdeficiency. Taken together, our data revealed specificity of E2F8 in mediating Rb function in erythropoiesis and suggest critical and overlapping roles of Rb and E2f8 in maintaining normal erythropoiesis and in preventing hemolysis.
Introduction
The role of the retinoblastoma (Rb) tumor suppressor in embryonic erythropoiesis was initially recognized when Rb knockout embryos were analyzed. [1] [2] [3] These embryos develop anemia with increased immature, nucleated red blood cells (RBCs) . Further investigations using conditional knockout approaches, chimeric approaches, or in vitro assays led to controversies on how Rb controls hematopoiesis. 4, 5 The main controversy is centered on the cell autonomous vs. non-cell autonomous action of Rb in the control of hematopoiesis. While non-cell autonomous role of Rb in the control of hematopoiesis has been established in the placenta, fetal liver macrophages, and the bone marrow (BM) niche, Rb plays a cell autonomous role in stress erythropoiesis and in an in vitro erythroid differentiation system. [6] [7] [8] [9] [10] [11] More recently, an erythroid-specific role of Rb in postnatal erythropoiesis has been identified.
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The role of Rb in the control of adult hematopoiesis has recently been established by using conditional knockout mouse models. Inactivation of Rb specifically in hematopoietic stem cells (HSCs) led to a mild anemia, moderate splenomegaly, abnormal expansion of erythroblasts in the spleen, myeloproliferation, and suppression of B lymphopoiesis in the BM. 7, 10 In addition, using an erythroid-specific conditional knockout system, Orkin and colleagues demonstrated that Rb intrinsically promotes adult erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis.
Previous studies have well documented important roles of E2F transcription factors in mediating Rb function. 13, 14 In quiescent cells, Rb binds and inhibits E2Fs, preventing E2F-mediated transcriptional activation of genes that are required for S phase entry and cell cycle progression. Upon mitogenic signaling, quiescent cells relay series of signaling transduction cascades that involve the activation of cyclin-dependent kinases and the phosphorylation and inactivation of Rb, leading to the subsequent release of E2Fs. 15, 16 In mammalian cells, there are eight known E2f genes (E2f1-8), with the E2f3 locus encoding two isoforms (3a and 3b).
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Based on their structural and biochemical properties, E2Fs can be divided into three groups. E2F1, E2F2, and E2F3a are considered as transcriptional activators, whose activities peak during the G1/S transition when released from the Rb binding. 15, 16 On the other hand, E2F3b, E2F4, and E2F5 are considered as transcriptional repressors and bind to Rb or other pocket proteins (i.e. p107 and p130) in quiescent cells to repress target genes. E2F6, E2F7, and E2F8 are also classified as repressors. Unlike E2F1-5, however, they do not have an Rb pocket protein-binding domain. 17, 18 Therefore, their function is thought to be independent of pocket protein binding. Although E2F6-dependent transcriptional repression is mediated through its ability to recruit the polycomb repressor complex, 19 it is unclear how E2F7 and E2F8 are involved in transcriptional repression. Given the interaction between Rb pocket proteins and E2F1-5, it is expected that Rb function can be mediated through various E2F activities. Indeed, numerous studies confirmed that E2Fs are important mediators for Rb function. [20] [21] [22] [23] [24] [25] [26] [27] In particular,
Macleod and colleagues recently showed that the terminal differentiation defect in Rb-null erythroblasts was suppressed by loss of E2f2. 28 However, it is unclear whether non-pocket protein-binding E2Fs, namely E2F6, E2F7, and E2F8, can functionally interact with Rb to mediate its function in vivo.
In an effort to understand whether non-pocket protein-binding E2Fs can mediate Rb function in the hematopoietic system, we uncovered a potent functional synergy between Rb loss and E2f8 loss to induce severe anemia. Mice with HSCs deficient for both Rb and E2f8
For personal use only. on September 13, 2017. by guest www.bloodjournal.org From suffer from marked ineffective erythropoiesis and mild hemolysis, leading to severe anemia despite the presence of regenerative response and active erythropoiesis. Interestingly, inactivation of E2f7, which shares all key functional domains and biochemical features with E2f8, 18 does not significantly exacerbate the mild anemia observed in mice with HSCs deficient for Rb. Thus, our data not only demonstrate the functional interaction of Rb and E2F8 to ensure normal erythropoiesis likely by promoting erythroid terminal differentiation and by maintaining erythrocyte membrane integrity, but also suggest possible roles of Rb and E2F8 in preventing hemolysis in humans.
Materials and methods Mice
All mouse lines used in this study have been described previously. [29] [30] [31] [32] Induction of Mx1-Cre was achieved by 3-7 intraperitoneal injections of 400ug of pIpC (Sigma) every other day on 4-weeks old mice. Mice were harvested 12 weeks post-pIpC injection. EpoR-GFPCre-mediated knockout mice were harvested at three months of age. All animal protocols were approved by the IACUC committee at New Jersey Medical School.
Immunofluorescence staining
Immunofluorescence staining was performed as described 36 with minor modifications.
Permeabilized RBCs were stained with rhodamine-phalloidin (Molecular Probes), and counterstained with Sytox green (Molecular Probes) to exclude reticulocytes and leukocytes for quantifications.
Statistical analysis
Values are presented as mean ± SD. Statistical significance was determined by Student t test with a significance threshold of 0.05.
Results

Concomitant inactivation of Rb and E2f8 results in severe anemia
To determine whether E2F7 and E2F8 can mediate Rb function, we inactivated Rb, E2f7, and E2f8 in HSCs by an interferon-inducible system with the Mx1-Cre allele.
30 Semi-quantitative PCR confirmed the efficient deletion of Rb, E2f7, and E2F8 in whole BMs ( Figure S1 , and data not shown Figure 1D ). However, there were no significant differences in BM cellularity among all genotypic groups ( Figure S2 ). Histological examination of hematoxylin-and eosin-stained spleen sections indicated that unlike spleens from control mice and Rb those from control mice, there was a decrease in late erythroids and an increase in early erythroids ( Figure 1H -J). Since there was a substantial myeloid expansion in the BM of the Rb Figure S4 ), the increased percentage of early erythroids in the BM, coupled with the substantial increases of early erythroids in the spleen, suggests active erythroid regeneration in response to the anemia. Consistent with this notion, Rb
10-fold increase in erythropoietin levels, a 4.5-fold increase in circulating reticulocytes, and increased nucleated RBC, anisocytosis (increased RDW), and polychromasia in their peripheral blood ( Figure S5 , Table 1 ). In addition, BrdU incorporation analysis of early erythroids of spleens and BM revealed significantly higher percentages of S phase cells and significantly lower percentages of G1 phase cells in Rb Figure 1K -L). These data suggest that early erythroids in Rb
Δ /Δ mice were highly proliferating. On the other hand, early erythroids from both spleens and BMs showed similar levels of apoptosis among different genotypic groups ( Figure S3 ), suggesting that the expansion of early erythroids likely resulted from increased proliferation instead of decreased apoptosis. As observed in many anemic mouse models where the spleen is the major source of increased red cell production due to limited capacity of BM expansion, HSCs and progenitors are significantly reduced in the BM and increased in the spleen of Rb Figure 3A -B) . Consistent with these data, significant decreases of BM in vivo day 8 and 12 colony-forming unit-spleen (CFU-S) and expansions of lineage-committed progenitors (CFU-GEMM, CFU-GM and BFU-E) in the spleens were also observed in those mice ( Figure 3C -G). Consistent with myeloproliferation and expansions of early erythroids in the BM (Figure 1, S4) , both BFU-E and CFU-GM populations were significantly increased in the BM of Rb Figure 3H ).
Impaired erythroid differentiation in Rb
Together, these data suggest that in Rb 
Erythroid-intrinsic role of Rb and E2f8 in maintaining normal erythropoiesis and preventing hemolysis
Our data show that inactivation of E2f8 synergizes with Rb-deficiency to induce severe anemia. To determine whether the role of Rb and E2f8 in regulating erythropoiesis is cell autonomous, we transplanted BM cells into lethally irradiated wild-type mice. Because inactivation of Rb and E2f8 causes HSC depletion in the BM, lethally irradiated mice receiving the standard number (2 x 10 6 ) of Rb Figure 4 ). Together, these data suggest that the functional interaction of Rb and E2F8 in erythropoiesis is cell autonomous. In addition, inactivation of Rb and E2f8 specifically in the erythroid lineage by the EpoR-GFPCre allele 29 also recapitulated the synergy of Rb-and E2f8-loss in triggering severe anemia that was resulted from both ineffective erythropoiesis and hemolysis ( Figure 5A -H, S9). These data support that the collaborative role of Rb and E2f8 in maintaining normal erythropoiesis and preventing hemolysis is erythroid intrinsic.
Discussion
Using conditional knockout mouse models we uncovered a potent and erythroid-intrinsic synergy of inactivation of E2f8 and Rb to trigger severe anemia. Our data represent the first evidence that a specific E2F family member that does not have a consensus pocket proteinbinding domain can functionally interact with a pocket protein in vivo. We found that although deletion of Rb or E2f8 in HSCs leads to mild erythropoietic defects (for Rb) or almost no defect (for E2f8), concomitant inactivation of both genes significantly exacerbates the erythropoietic defect resulted from Rb-deficiency, leading to severe anemia. We further showed that the severe anemia in the Rb Δ /Δ mice are responsive to the anemia, evidenced by the enhanced but still ineffective erythropoiesis and increased circulating reticulocyte counts. However, the underlying ineffective erythropoiesis and persistent mild hemolysis still render the mice severely anemic. Therefore, the steady reticulocytosis observed in the Rb (Table 1) is not an indicator of effective erythropoiesis, but rather reflections of regenerative erythropoiesis, the premature release of immature reticulocytes to the peripheral circulation to compensate for the severe anemia, and the longer time for such reticulocytes to mature into RBC in the peripheral circulation.
During their life span, RBCs face strong circulatory shearing forces through circulation and micro-circulation. Therefore, they must be flexible to pass safely through blood vessels and capillaries. The deformability and durability of RBCs are largely controlled by membrane skeletal proteins. In patients with hemolytic anemia, mutations causing defects in one or more membrane skeletal proteins have often been found. 38 In the last decade, many mouse models for hemolytic anemia with spontaneous mutations or targeted disruptions of genes encoding membrane skeletal proteins have been generated. Data from these models further support the important role of erythrocyte membrane skeletal proteins. 38 In addition, hemolysis may also arise from impaired glucose metabolism, hemoglobin synthesis, or defective erythrocyte membrane permeability. [39] [40] [41] [42] However, it remains largely unknown how these critical proteins are regulated. In the present study, we showed that inactivation of Rb and E2f8 in erythroids synergizes to trigger hemolysis ( Figure 2 ). Increased osmotic fragility, impaired deformability, and abnormal morphologies of Rb
E2f8
Δ /Δ erythrocytes suggest that the increased hemolysis is possibly due to impaired red cell membrane integrity. In addition, defective down-regulation of CD71 was also found in the Rb
Δ /Δ reticulocytes, suggesting a membrane-remodeling defect during the reticulocyte maturation process. Many factors can contribute to the erythrocyte membrane integrity, such as depleted cytoskeletal membrane proteins, abnormal partitioning of such proteins into various protein complexes, or defective membrane physiology such as a sodium leak or other ion channel defects. Given the important role of Rb in oxidative stress response 4 and mitochondrial biogenesis, 12 increased oxidative stress and/or abnormal mitochondrial activities can also be the culprit of hemolysis in the Rb
As the two recently identified E2F transcriptional repressors, E2F7 and E2F8 share several unique features that distinguish them from other members in the E2F family.
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Consistent with their high levels of structural and biochemical similarities, E2F7 and E2F8 are functionally redundant during early mouse development as E2f7 -/-E2f8 -/-embryos die in uterus even though E2f7 or E2f8 knockout mice are viable. 31 In the present study, we identified a unique synergy between loss of E2f8 (but not E2f7) and Rb-deficiency to induce severe anemia. It will be interesting to know whether the difference between E2F7 and E2F8 in mediating Rb function is due to their differential promoter regulations or their different protein identities. Since E2F8 lacks a Rb pocket protein-binding domain, 18 its functional interaction with Rb is likely independent of pocket protein binding. Considering the co-repressor role of Rb and the transcriptional repressor role of E2F8, we speculate that the potent synergy is most likely due to transcriptional de-regulation or derepression of critical E2F targets gene(s) involved in maintaining normal erythropoiesis and in preventing hemolysis. While the precise molecular mechanism underlying the synergy remains to be delineated, we propose two possible molecular mechanisms to explain how E2F8 can 1 0 functionally interact with Rb to prevent target gene de-regulation and severe anemia. The first possibility is the direct and overlapping down-regulation of critical targets by Rb and E2F8. In this context, Rb and E2F8 may repress either the same critical targets or different critical targets that are redundant to prevent anemia. As a transcriptional co-repressor, in the absence of E2F8, Rb can impose active transcriptional repression of target genes by its association with repressor complexes. On the other hand, in the absence of Rb, as a transcriptional repressor E2F8 can maintain active repression. In the absence of both genes, however, critical target(s) would be de-regulated. The fact that Rb can interact with various hematopoietic/erythroid transcription factors such as GATA-1, PU1 and EKLF [43] [44] [45] suggests that Rb may exert its co-repressor function by repressing critical targets for erythropoiesis. The second possibility is the involvement of an activator E2F (E2F1-3) that regulates target genes important for maintaining normal erythropoiesis and for preventing hemolysis. In this context, Rb can bind to the activator E2F and prevent E2F-mediated transcriptional activation of target genes. As a transcriptional repressor, E2F8 can either repress the activator E2F or compete with it for E2F binding sites of target gene promoters. In the absence of Rb, while the activator E2F is expected to be free from Rb binding and inhibition, E2F8 can still repress the activator E2F or occupy its E2f binding sites of target gene promoters to maintain relatively normal regulation of the target genes.
In the absence of E2f8, Rb binding and inhibition of the activator E2F may be sufficient to prevent aberrant activation of E2F target genes. However, in the absence of both genes, the activator E2F can be de-regulated, leading to aberrant activation of target genes. The involvement of E2F2 in mediating Rb function in embryonic erythropoiesis 28 raises an intriguing possibility that E2F2 is a relevant activator E2F responsible for the synergy in adult erythropoiesis. Consistent with this possibility, E2F2 has been functionally linked to GATA-1 and EKLF, two important erythroid transcription factors that are critical for erythroid terminal differentiation 28, 43, 44 and are implicated in hemolysis.
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